CAT-2054

DRUG2 trials

Sponsors

Catabasis Pharmaceuticals

Conditions

Hypercholesterolemia

Phase 1

A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects

CompletedNCT02374047

Catabasis PharmaceuticalsHypercholesterolemia

Start: 2015-01-31End: 2015-07-31Updated: 2021-01-28

Phase 2

A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia

CompletedNCT02608697

Catabasis PharmaceuticalsHypercholesterolemia

Start: 2015-10-31End: 2016-06-30Updated: 2017-06-20